Phase II trial of Liposomal Grb-2 (BP 100-1-01) combination salvage therapy in patients with acute myeloid leukaemia
Phase of Trial: Phase II
Latest Information Update: 11 May 2016
At a glance
- Drugs Prexigebersen (Primary) ; Cytarabine
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 11 May 2016 According to a Bio-Path Holdings media release, this trial is enrolling patients in the efficacy part of the trial.
- 03 Mar 2016 According to a Bio-Path Holdings media release, the company is in the process of submitting the results from this trial to the US FDA and is planning to open the efficacy portion of the Phase II trial of BP1001 in the second quarter of 2016.
- 03 Mar 2016 Results from the eighth and final cohort of the safety segment of this trial published in a Bio-Path Holdings media release.